News

Featured News

  • 2022 |
  • 2021 |
  • 2020 |
  • 2019 |
  • 2018 |
  • 2017 |
  • View All
  • Press Release | February 28, 2022

    Freenome Launches the Vallania Study for the Early Detection of Multiple Cancers

    Read More

    News | February 28, 2022

    Aptinyx Completes Enrollment in Phase 2b Study of NYX-2925 in Fibromyalgia

    Read More

    Press Release | February 24, 2022

    Pliant Therapeutics Announces Positive DSMB Safety Review and Commencement of Enrollment of Phase 2a Trial of PLN-74809 at 320 mg Dose in Idiopathic Pulmonary Fibrosis

    Read More

    Press Release | February 3, 2022

    Orchard Therapeutics Announces Historic Agreement Making Libmeldy Available by NHS England for MLD Patients

    Read More